Side-by-side comparison of AI visibility scores, market position, and capabilities
Conceivable Life provides personalized fertility coaching and integrative health programs combining nutrition, acupuncture, and lifestyle guidance to optimize fertility outcomes.
Conceivable Life is a fertility wellness company founded in 2013 that provides evidence-based integrative health programs for people preparing for or undergoing fertility treatment. The platform combines personalized nutritional guidance, acupuncture protocols, stress reduction techniques, and lifestyle coaching that research suggests can improve fertility outcomes and reduce stress during the fertility journey. Conceivable serves both self-pay consumers seeking to optimize their fertility naturally and patients undergoing IVF who want to maximize their treatment success through complementary health practices. The company delivers its programs primarily online through an app and virtual coaching sessions with certified fertility wellness coaches and integrative health practitioners. Conceivable has raised funding and built evidence-based protocols drawing on research in functional medicine, epigenetics, and reproductive science. As fertility treatment patients increasingly seek integrative approaches that address the whole-person factors influencing reproductive success, Conceivable addresses an underserved market for clinically grounded fertility wellness that sits alongside rather than competing with conventional fertility medicine.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.